Cenobamate

Cenobamate in the Intensive Care Unit

Open-label Study of Cenobamate Monotherapy in Adult Subjects With Newly Diagnosed or Recurrent Partial-Onset Epilepsy

Cenobamate Open-Label Extension Study for YKP3089C025

Real-world Clinical Response to Cenobamate Early add-on in France, Germany and Spain

Randomized, Double-Blind Study to Evaluate Efficacy and Safety of Cenobamate Adjunctive Therapy in PGTC Seizures

ONO-2017 Study Japanese Patients With Primary Generalized Tonic Clonic Seizures.

Safety of Cenobamate in Japanese Subjects With Partial Onset Seizures

A Study of the Abuse Liability Potential of Cenobamate in Recreational Drug Users

A Randomized, Open-label, Three-way Crossover Study to Evaluate the Relative Bioavailability of 200 Mg Cenobamate Administered Orally

Assess the Influence of Cenobamate on the PK of Cytochrome P450 (CYP) Probe Drugs As a Means of Predicting Drug-drug Interactions

Safety Study of Cenobamate in Subjects With Normal Hepatic Function and Subjects With Severe Hepatic Impairment

Randomized, Double-blind Study to Evaluate Efficacy and Safety of Cenobamate Adjunctive Therapy in POS